![](/img/cover-not-exists.png)
Authors’ Reply to Tsivgoulis et al.: “Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A likelihood to Achieve No Evidence of Disease Activity or Harm Analysis”
Papadopoulos, Dimitrios, Mitsikostas, Dimos-Dimitrios D.Language:
english
Journal:
CNS Drugs
DOI:
10.1007/s40263-019-00616-4
Date:
February, 2019
File:
PDF, 325 KB
english, 2019